Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards

August 21, 2023 at 08:56 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is thrilled to announce NeuroStar Advanced Therapy’s “Tap Into A New Possibility for Depression” campaign has been awarded Gold by the 2023 dotCOMM Awards in the category of Digital Marketing & Communication Campaigns.

“This award is a recognition of our efforts to not only raise awareness about NeuroStar, but to also educate patients and guide their path to treatment. A priority for us as a company is to make it easy for patients to get the help they need, and to support the physician practices that are in the trenches, fighting depression alongside these patients each day,” stated Lisa Metzner-Rosas, Senior Vice President, Chief Marketing Officer, of Neuronetics Inc. “We look forward to evolving our campaign and strategy to support even more customers and their patients this year.”

The dotCOMM Awards is an annual international competition that honors merit in web creativity and digital communication. Administered and judged by the Association of Marketing and Communication Professionals (AMCP), a globally renowned and esteemed evaluator of creative work, the awards celebrate the best achievements in the field. There were over 2,500 entries from throughout the United States, Canada and internationally across 241 categories.

Neuronetics’ marketing team, with creative partner Hyperquake, has recently expanded the “Tap Into A New Possibility for Depression” campaign, shifting the spotlight onto the inspirational journeys of numerous patients who triumphed over depression and found their way to recovery with the help of NeuroStar Advanced Therapy.

For more information about NeuroStar TMS Therapy, please visit NeuroStar.com.

About Neuronetics
Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn’t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5.6 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world’s largest depression Outcomes Registry. Neuronetics is committed to transforming lives by offering an exceptional treatment that produces extraordinary results. For safety and prescribing information, www.neurostar.com.

Media Contact:
EvolveMKD
646.517.4220
NeuroStar@evolvemkd.com